461 related articles for article (PubMed ID: 16371043)
1. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.
Laroche V; McKenna DH; Moroff G; Schierman T; Kadidlo D; McCullough J
Transfusion; 2005 Dec; 45(12):1909-16. PubMed ID: 16371043
[TBL] [Abstract][Full Text] [Related]
2. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
3. A novel high-yield volume-reduction method for the cryopreservation of UC blood units.
Koliakos G; Alamdari D; Tsagias N; Kouzi-Koliakos K; Michaloudi E; Karagiannis V
Cytotherapy; 2007; 9(7):654-9. PubMed ID: 17917886
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cord blood thawing methods on cell recovery, potency, and infusion.
Regan DM; Wofford JD; Wall DA
Transfusion; 2010 Dec; 50(12):2670-5. PubMed ID: 21126251
[TBL] [Abstract][Full Text] [Related]
5. A new automated cell washer device for thawed cord blood units.
Perotti CG; Del Fante C; Viarengo G; Papa P; Rocchi L; Bergamaschi P; Bellotti L; Marchesi A; Salvaneschi L
Transfusion; 2004 Jun; 44(6):900-6. PubMed ID: 15157258
[TBL] [Abstract][Full Text] [Related]
6. Washing of cord blood grafts after thawing: high cell recovery using an automated and closed system.
Rodríguez L; Azqueta C; Azzalin S; García J; Querol S
Vox Sang; 2004 Oct; 87(3):165-72. PubMed ID: 15569068
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
Rodríguez L; Velasco B; García J; Martín-Henao GA
Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
[TBL] [Abstract][Full Text] [Related]
8. Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood.
Yang H; Zhao H; Acker JP; Liu JZ; Akabutu J; McGann LE
Cryobiology; 2005 Oct; 51(2):165-75. PubMed ID: 16111670
[TBL] [Abstract][Full Text] [Related]
9. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pairwise analysis of umbilical cord blood units and cryopreserved aliquots.
Flores AI; McKenna DH; Montalbán MA; De la Cruz J; Wagner JE; Bornstein R
Transfusion; 2009 Apr; 49(4):636-47. PubMed ID: 19055702
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing cord blood viability assessment before cryopreservation.
Solomon M; Wofford J; Johnson C; Regan D; Creer MH
Transfusion; 2010 Apr; 50(4):820-30. PubMed ID: 19919556
[TBL] [Abstract][Full Text] [Related]
11. Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative?
Van haute I; Lootens N; De Smet S; De Buck C; Verdegem L; Vanheusden K; Pinxteren J; Vandekerckhove B
Transfusion; 2004 Apr; 44(4):547-54. PubMed ID: 15043571
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cord blood hematopoietic cell parameters before and after cryopreservation.
Kurtz J; Seetharaman S; Greco N; Moroff G
Transfusion; 2007 Sep; 47(9):1578-87. PubMed ID: 17725720
[TBL] [Abstract][Full Text] [Related]
13. Effect of umbilical cord blood prefreeze variables on postthaw viability.
Pope B; Hokin B; Grant R
Transfusion; 2015 Mar; 55(3):629-35. PubMed ID: 25332061
[TBL] [Abstract][Full Text] [Related]
14. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.
Tijssen MR; Woelders H; de Vries-van Rossen A; van der Schoot CE; Voermans C; Lagerberg JW
Transfusion; 2008 May; 48(5):893-901. PubMed ID: 18298597
[TBL] [Abstract][Full Text] [Related]
15. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.
Cairo MS; Wagner EL; Fraser J; Cohen G; van de Ven C; Carter SL; Kernan NA; Kurtzberg J
Transfusion; 2005 Jun; 45(6):856-66. PubMed ID: 15934982
[TBL] [Abstract][Full Text] [Related]
16. Multi-laboratory evaluation of procedures for reducing the volume of cord blood: influence on cell recoveries.
Takahashi TA; Rebulla P; Armitage S; van Beckhoven J; Eichler H; Kekomäki R; Letowska M; Wahab F; Moroff G
Cytotherapy; 2006; 8(3):254-64. PubMed ID: 16793734
[TBL] [Abstract][Full Text] [Related]
17. Evaluations of bioantioxidants in cryopreservation of umbilical cord blood using natural cryoprotectants and low concentrations of dimethylsulfoxide.
Motta JP; Gomes BE; Bouzas LF; Paraguassú-Braga FH; Porto LC
Cryobiology; 2010 Jun; 60(3):301-7. PubMed ID: 20152822
[TBL] [Abstract][Full Text] [Related]
18. Viability does not necessarily reflect the hematopoietic progenitor cell potency of a cord blood unit: results of an interlaboratory exercise.
Brand A; Eichler H; Szczepiorkowski ZM; Hess JR; Kekomaki R; McKenna DH; Pamphilon D; Reems J; Sacher RA; Takahashi TA; van de Watering LM;
Transfusion; 2008 Mar; 48(3):546-9. PubMed ID: 18067495
[TBL] [Abstract][Full Text] [Related]
19. Optimization of cryopreservation condition for hematopoietic stem cells from umbilical cord blood.
Son JH; Heo YJ; Park MY; Kim HH; Lee KS
Cryobiology; 2010 Jun; 60(3):287-92. PubMed ID: 20138169
[TBL] [Abstract][Full Text] [Related]
20. Effects of interruptions of controlled-rate freezing on the viability of umbilical cord blood stem cells.
Yang H; Pidgorna A; Loutfy MR; Shuen P
Transfusion; 2015 Jan; 55(1):70-8. PubMed ID: 25039650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
